The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial

被引:2
作者
Guirgis, Faheem W. [1 ]
Black, Lauren Page [2 ]
Henson, Morgan [2 ]
Bertrand, Andrew [1 ]
Devos, Elizabeth [2 ]
Ferreira, Jason [3 ]
Gao, Hanzhi [4 ,5 ]
Wu, Samuel S. [4 ,5 ]
Leeuwenburgh, Christiaan [6 ]
Moldawer, Lyle [7 ]
Moore, Frederick [7 ]
Reddy, Srinivasa T. [8 ]
机构
[1] Univ Florida, Coll Med, Dept Emergency Med, Gainesville, FL 32603 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA
[3] Univ Florida, Coll Med, Div Pulm & Crit Care Med, Dept Med, Jacksonville, FL USA
[4] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA
[5] Univ Florida, Coll Med, Gainesville, FL USA
[6] Univ Florida, Coll Med, Dept Physiol & Aging, Gainesville, FL USA
[7] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA
[8] Univ Calif Los Angeles, Dept Med, Coll Med, Los Angeles, CA USA
关键词
cholesterol; lipid emulsion; lipids; organ failure; parenteral nutrition; sepsis; septic shock; DENSITY-LIPOPROTEIN CHOLESTEROL; SEPTIC SHOCK; SURVIVAL; PROFILES; EMULSION; OUTCOMES; IMPACT; LEVEL;
D O I
10.1097/CCM.0000000000006268
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
OBJECTIVES: Low cholesterol levels in early sepsis patients are associated with mortality. We sought to test if IV lipid emulsion administration to sepsis patients with low cholesterol levels would prevent a decline or increase total cholesterol levels at 48 hours. DESIGN: Phase II, adaptive, randomized pilot clinical trial powered for 48 patients. SETTING: Emergency department or ICU of an academic medical center. PATIENTS: Sepsis patients (first 24 hr) with Sequential Organ Failure Assessment greater than or equal to 4 or shock. INTERVENTIONS: Patients meeting study criteria, including screening total cholesterol levels less than or equal to 100 mg/dL or high-density lipoprotein cholesterol (HDL-C) + low-density lipoprotein cholesterol (LDL-C) less than or equal to 70 mg/dL, were randomized to receive one of three doses of lipid emulsion administered twice in 48 hours or no drug (controls). The primary endpoint was a change in serum total cholesterol (48 hr - enrollment) between groups. MEASUREMENTS AND MAIN RESULTS: Forty-nine patients were enrolled and randomized. Two patients randomized to lipid emulsion were withdrawn before drug administration. Data for 24 control patients and 23 lipid emulsion patients were analyzed. The mean change in total cholesterol from enrollment to 48 hours was not different between groups and was 5 mg/dL (sd 20) for lipid emulsion patients, and 2 mg/dL (sd 18) for control patients (p = 0.62). The mean changes in HDL-C and LDL-C were similar between groups. Mean change in triglycerides was elevated in lipid emulsion patients (61 mg/dL, sd 87) compared with controls (20 mg/dL, sd 70, p = 0.086). The 48-hour change in SOFA score was -2 (interquartile range [IQR] -4, -1) for control patients and -2 (IQR -3, 0) for lipid emulsion patients (p = 0.46). CONCLUSIONS: Administration of IV lipid emulsion to early sepsis patients with low cholesterol levels did not influence change in cholesterol levels from enrollment to 48 hours.
引用
收藏
页码:1183 / 1193
页数:11
相关论文
共 33 条
  • [11] The Development of Chronic Critical Illness Determines Physical Function, Quality of Life, and Long-Term Survival Among Early Survivors of Sepsis in Surgical ICUs
    Gardner, Anna K.
    Ghita, Gabriela L.
    Wang, Zhongkai
    Ozrazgat-Baslanti, Tezcan
    Raymond, Steven L.
    Mankowski, Robert T.
    Brumback, Babette A.
    Efron, Philip A.
    Bihorac, Azra
    Moore, Frederick A.
    Anton, Stephen D.
    Brakenridge, Scott C.
    [J]. CRITICAL CARE MEDICINE, 2019, 47 (04) : 566 - 573
  • [12] Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial
    Guirgis, Faheem W.
    Black, Lauren Page
    DeVos, Elizabeth
    Henson, Morgan
    Ferreira, Jason
    Miller, Taylor
    Rosenthal, Martin
    Leeuwenburgh, Christiaan
    Kalynych, Colleen
    Moldawer, Lyle
    Jones, Lisa
    Crandall, Marie
    Reddy, Srinivasa T.
    Gao, Hanzhi
    Wu, Sam
    Moore, Frederick
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2020, 1 (06) : 1332 - 1340
  • [13] LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock
    Guirgis, Faheem W.
    Black, Lauren Page
    Rosenthal, Martin Daniel
    Henson, Morgan
    Ferreira, Jason
    Leeuwenburgh, Christiaan
    Kalynych, Colleen
    Moldawer, Lyle L.
    Miller, Taylor
    Jones, Lisa
    Crandall, Marie
    Reddy, Srinivasa T.
    Wu, Samuel S.
    Moore, Frederick A.
    [J]. BMJ OPEN, 2019, 9 (09):
  • [14] Cholesterol levels and long-term rates of community-acquired sepsis
    Guirgis, Faheem W.
    Donnelly, John P.
    Dodani, Sunita
    Howard, George
    Safford, Monika M.
    Levitan, Emily B.
    Wang, Henry E.
    [J]. CRITICAL CARE, 2016, 20
  • [15] The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients
    Hall, Thomas C.
    Bilku, Dilraj K.
    Neal, Christopher P.
    Cooke, Jill
    Fisk, Helena L.
    Calder, Philip C.
    Dennison, Ashley R.
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2016, 112 : 1 - 11
  • [16] A Randomized Controlled Trial Investigating the Effects of Parenteral Fish Oil on Survival Outcomes in Critically Ill Patients With Sepsis: A Pilot Study
    Hall, Thomas C.
    Bilku, Dilraj K.
    Al-Leswas, Dhya
    Neal, Christopher P.
    Horst, Cindy
    Cooke, Jill
    Metcalfe, Matthew S.
    Dennison, Ashley R.
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2015, 39 (03) : 301 - 312
  • [17] Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
    Harris, Paul A.
    Taylor, Robert
    Thielke, Robert
    Payne, Jonathon
    Gonzalez, Nathaniel
    Conde, Jose G.
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) : 377 - 381
  • [18] Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis
    Hofmaenner, Daniel A.
    Arina, Pietro
    Kleyman, Anna
    Black, Lauren Page
    Salomao, Reinaldo
    Tanaka, Sebastien
    Guirgis, Faheem W.
    Arulkumaran, Nishkantha
    Singer, Mervyn
    [J]. CRITICAL CARE EXPLORATIONS, 2023, 5 (02) : E0860
  • [19] Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
    Kumar, Anand
    Zarychanski, Ryan
    Light, Bruce
    Parrillo, Joseph
    Maki, Dennis
    Simon, Dave
    Laporta, Denny
    Lapinsky, Steve
    Ellis, Paul
    Mirzanejad, Yazdan
    Martinka, Greg
    Keenan, Sean
    Wood, Gordon
    Arabi, Yaseen
    Feinstein, Daniel
    Kumar, Aseem
    Dodek, Peter
    Kravetsky, Laura
    Doucette, Steve
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (09) : 1773 - 1785
  • [20] Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis
    Lekkou, Alexandra
    Mouzaki, Athanassia
    Siagris, Dimitrios
    Ravani, Ifigenia
    Gogos, Charalambos A.
    [J]. JOURNAL OF CRITICAL CARE, 2014, 29 (05) : 723 - 727